Quick Answer
ABEONA THERAPEUTICS INC. reported Total Revenue of $5.82 million for the year ending 2025.
- ABEONA THERAPEUTICS INC. showed an increase of +66.3% in Total Revenue from 2023 to 2025.
- This data is from ABEONA THERAPEUTICS INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $219.0 thousand | Q1 2018: $531.0 thousand | Q2 2018: $276.0 thousand | Q3 2018: $1.71 million | Q3 2018: $1.71 million | Q1 2019: $0.00 | Q2 2019: $0.00 | Q3 2020: $7.00 million | Q1 2022: $346.0 thousand | Q2 2022: $1.00 million | Q2 2023: $3.50 million | Q2 2025: $400.0 thousand.
- Over the full 10 years of available data (2016 to 2025), ABEONA THERAPEUTICS INC.'s Total Revenue has grown by 554.7%.
- Historical annual values: Fiscal year 2025: $5.82 million | Fiscal year 2023: $3.50 million | Fiscal year 2022: $1.41 million | Fiscal year 2021: $3.00 million | Fiscal year 2020: $10.00 million | Fiscal year 2018: $3.00 million | Fiscal year 2018: $3.00 million | Fiscal year 2017: $837.0 thousand | Fiscal year 2017: $837.0 thousand | Fiscal year 2016: $889.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: